Haemonetics | HAE - Cash And Equivalent


Haemonetics reported $363.37M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Avanos Medical USD 89.8M 19.3M Dec/2025
Baxter International USD 1.97B 240M Dec/2025
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Boston Scientific USD 1.96B 690M Dec/2025
Cerus USD 15.67M 321K Sep/2025
Cooper Companies USD 110.6M 14.3M Sep/2025
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.58B 326.57M Dec/2025
Globus Medical USD 526.16M 154.39M Dec/2025
Haemonetics USD 363.37M 66.94M Dec/2025
ICU Medical USD 307.96M 8.23M Dec/2025
Intuitive Surgical USD 7.98B 1.05B Mar/2026
Masimo USD 312.3M 162.7M Sep/2025
Medtronic USD 1.15B 135M Dec/2025
Merit Medical Systems USD 446.4M 53.95M Dec/2025
Neogen USD 159.9M 14.56M Dec/2025
OraSure Technologies USD 199.28M 17.2M Dec/2025
Plus Therapeutics USD 4.26M 9.03M Dec/2025
Quidel USD 169.8M 71.7M Dec/2025
ResMed USD 1.42B 33.22M Dec/2025
STAAR Surgical USD 153.15M 23M Dec/2025
Steris USD 423.7M 104.5M Dec/2025
Stryker USD 4.01B 755M Dec/2025
Surmodics USD 36.11M 11.81M Sep/2024
Teleflex USD 354M 100.3M Sep/2025
Terumo JPY 217.16B 12.86B Sep/2025
Thermo Fisher Scientific USD 3.25B 6.6B Mar/2026
US Physical Therapy USD 35.57M 4.47M Dec/2025
Zimmer Biomet Holdings USD 591.9M 700.8M Dec/2025